Selected article for: "drug discovery and experimental structure"
Author: Hillisch, Alexander; Pineda, Luis Felipe; Hilgenfeld, Rolf
Title: Utility of homology models in the drug discovery process
  • Cord-id: 02bik024
  • Document date: 2004_7_25
    • ID: 02bik024
    Snippet: Advances in bioinformatics and protein modeling algorithms, in addition to the enormous increase in experimental protein structure information, have aided in the generation of databases that comprise homology models of a significant portion of known genomic protein sequences. Currently, 3D structure information can be generated for up to 56% of all known proteins. However, there is considerable controversy concerning the real value of homology models for drug design. This review provides an over
    Document: Advances in bioinformatics and protein modeling algorithms, in addition to the enormous increase in experimental protein structure information, have aided in the generation of databases that comprise homology models of a significant portion of known genomic protein sequences. Currently, 3D structure information can be generated for up to 56% of all known proteins. However, there is considerable controversy concerning the real value of homology models for drug design. This review provides an overview of the latest developments in this area and includes selected examples of successful applications of the homology modeling technique to pharmaceutically relevant questions. In addition, the strengths and limitations of the application of homology models during all phases of the drug discovery process are discussed.

    Search related documents:
    Co phrase search for related documents
    • accuracy level and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7
    • accuracy level and additional information: 1, 2
    • acetic acid and active compound: 1
    • acetic acid and active site: 1, 2
    • activation binding and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • active compound and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • active site and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site and additional information: 1, 2
    • active site and low sequence: 1, 2, 3, 4, 5
    • active site and low sequence identity: 1
    • active site cysteine and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome and additional information: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and low sequence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory syndrome and low sequence identity: 1, 2, 3
    • additional information and low sequence: 1, 2